Owner

Untitled

Verification

🟥 MASTER TABLE 1 — Core Definition & Big Picture of Shock

Aspect	Details
Definition	State of diminished cardiac output OR reduced effective circulating blood volume
Immediate result	Impaired tissue perfusion
Cellular effect	Cellular hypoxia
Early phase	Injury reversible
Prolonged shock	Irreversible tissue injury, organ failure, often fatal

🟥 MASTER TABLE 2 — Clinical Contexts Where Shock Occurs

Trigger Category	Examples
Volume loss	Severe hemorrhage
Tissue injury	Extensive trauma, burns
Cardiac causes	Myocardial infarction
Vascular obstruction	Pulmonary embolism
Infection	Microbial sepsis

🟥 MASTER TABLE 3 — Major Categories of Shock (Core Types)

Type	Primary Mechanism	Key Causes	Core Logic
Cardiogenic	↓ Cardiac output	MI, ventricular arrhythmias, tamponade, massive PE	Heart cannot pump
Hypovolemic	↓ Cardiac output	Hemorrhage, burns, plasma loss	Not enough volume to pump
Septic	Distributive shock	Severe infection → SIRS	Vasodilation + leakage + pooling

🟥 MASTER TABLE 4 — Cardiogenic Shock (Expanded)

Cause Group	Examples
Myocardial damage	Acute MI
Arrhythmias	VT, VF
Extrinsic compression	Cardiac tamponade
Outflow obstruction	Massive pulmonary embolism

🟥 MASTER TABLE 5 — Hypovolemic Shock (Expanded)

Mechanism	Examples
Blood loss	Trauma, GI bleed, obstetric bleed
Plasma/fluid loss	Severe burns, dehydration, vomiting, diarrhea

🟥 MASTER TABLE 6 — Other Important Types of Shock

Type	Mechanism	Typical Setting
Neurogenic	Loss of sympathetic tone → vasodilation	Spinal injury, anesthesia
Anaphylactic	IgE-mediated hypersensitivity	Drugs, foods, insect stings

🟥 MASTER TABLE 7 — Septic Shock: Epidemiology

Parameter	Data
Hospital admissions	~2% (USA)
ICU requirement	~50%
Annual cases	~750,000
Mortality	20–30%
Rising incidence	Immunosuppression, MDR organisms, critical care survival

🟥 MASTER TABLE 8 — Septic Shock: Microbial Triggers

Category	Notes
Most common	Gram-positive bacteria
Others	Gram-negative bacteria, fungi
Terminology	“Endotoxic shock” outdated

🟥 MASTER TABLE 9 — Innate Immune Activation in Sepsis

Receptors / Systems

Toll-like receptors (TLRs)

GPCR peptide receptors

C-type lectins (Dectins)

Complement system

🟥 MASTER TABLE 10 — Septic Shock: Hyperinflammatory Response

Component	Examples
Cytokines	TNF, IL-1, IL-12, IL-18, IFN-γ
Lipid mediators	Prostaglandins, PAF
Others	ROS, HMGB1
Biomarkers	↑ CRP, ↑ Procalcitonin
Complement	C3a, C5a (anaphylatoxins); C3b (opsonin)
Coagulation link	Thrombin → protease-activated receptors

🟥 MASTER TABLE 11 — Compensatory Immunosuppression in Sepsis

Feature	Effect
TH1 → TH2 shift	Reduced cellular immunity
Anti-inflammatory mediators	IL-10, IL-1RA, soluble TNF receptor
Lymphocyte apoptosis	Immune paralysis
Clinical outcome	Superinfections

🟥 MASTER TABLE 12 — Endothelial Injury & Vascular Collapse

Mechanism	Effect
Tight junction loosening	Protein-rich edema
↑ NO, C3a, C5a, PAF	Vasodilation
IV fluids	Worsen edema
Net result	Distributive shock

🟥 MASTER TABLE 13 — Coagulation Abnormalities (DIC in Sepsis)

Procoagulant Changes	Consequence
↑ Tissue factor	Clot formation
↓ Protein C, thrombomodulin, TFPI	Loss of anticoagulation
↑ PAI-1	↓ Fibrinolysis
Stasis from edema	Thrombosis
Late phase	Bleeding (factor & platelet consumption)

🟥 MASTER TABLE 14 — Metabolic Abnormalities in Septic Shock

System	Abnormality
Glucose metabolism	Hyperglycemia, insulin resistance
Hormonal drivers	TNF, IL-1, cortisol, glucagon, GH, catecholamines
Immune effect	↓ Neutrophil function
Endocrine	Relative adrenal insufficiency
Special syndrome	Waterhouse-Friderichsen (adrenal necrosis)
Cellular respiration	↓ Oxidative phosphorylation
Acid–base	Lactic acidosis

🟥 MASTER TABLE 15 — Organ Dysfunction in Septic Shock

Organ	Mechanism
Kidneys	Hypotension, microthrombi
Liver	Hypoxia
Lungs	ARDS (shock lung)
Heart	Depressed contractility
Final outcome	Multiorgan failure

🟥 MASTER TABLE 16 — Stages of Shock (High-Yield Comparison)

Stage	Key Features	Reversibility
Nonprogressive	Neurohumoral compensation, tachycardia, vasoconstriction, cool skin (warm early sepsis)	Reversible
Progressive	Anaerobic glycolysis, lactic acidosis, vasodilation, DIC risk, organ dysfunction	Partially reversible
Irreversible	Lysosomal rupture, myocardial depression (↑ NO), ischemic gut, renal failure	Fatal

🟥 MASTER TABLE 17 — Morphology of Shock

Organ/System	Morphologic Change
General	Hypoxic injury
Kidneys	Fibrin thrombi (glomeruli)
Adrenals	Lipid depletion
Lungs	ARDS in sepsis/trauma
Recovery limits	Neurons, cardiomyocytes

🟥 MASTER TABLE 18 — Clinical Features by Shock Type

Shock Type	Skin	Other Features
Hypovolemic	Cool, clammy, cyanotic	Hypotension, tachycardia
Cardiogenic	Cool, clammy	Weak pulse, tachypnea
Septic (early)	Warm, flushed	Vasodilation

🟥 MASTER TABLE 19 — Prognosis

Scenario	Outcome
Young hypovolemic patients	>90% survival
Septic shock	Poor prognosis
Cardiogenic shock	Poor prognosis
Key determinant	Cause + duration

🟥 MASTER TABLE 20 — Treatment Principles

Strategy	Purpose
Antibiotics	Treat infection
IV fluids	Restore volume
Vasopressors	Maintain perfusion
Oxygen	Correct hypoxia
Cytokine blockade	Failed clinically

🟥 MASTER TABLE 21 — Superantigens & Toxic Shock

Feature	Detail
Organisms	S. aureus, S. pyogenes
Mechanism	Polyclonal T-cell activation
Result	Massive cytokine release
Clinical	Rash, hypotension, shock, death

Stage	Serum Lactate (mmol/L)	Pathophysiology	Clinical Meaning	Exam-Critical Notes
Normal	< 2	Adequate oxygen delivery; aerobic metabolism	Normal perfusion	Rules out tissue hypoxia
Early Sepsis / Compensated Shock	2 – 4	Early tissue hypoperfusion; ↑ anaerobic glycolysis	Occult shock possible; BP may be normal	Lactate ≥2 = red flag
Established Septic Shock	≥ 4	Severe hypoperfusion; microcirculatory failure; mitochondrial dysfunction	Defines septic shock; high mortality	Key diagnostic cutoff
Refractory / Late Septic Shock	Persistently ≥ 4–5	Ongoing cellular hypoxia despite resuscitation	Multiorgan failure	Very poor prognosis
Improving Shock (Lactate Clearance)	↓ ≥10–20% in 6 h	Restored perfusion & metabolism	Good response to treatment	Strong survival predictor

🟥 MASTER TABLE 3 — Major Categories of Shock (Core Types)

Type	Primary Mechanism	Key Causes	Core Logic
Cardiogenic	↓ Cardiac output	MI, ventricular arrhythmias, tamponade, massive PE	Heart cannot pump
Hypovolemic	↓ Cardiac output	Hemorrhage, burns, plasma loss	Not enough volume to pump
Septic	Distributive shock	Severe infection → SIRS	Vasodilation + leakage + pooling

🟥 MASTER TABLE 14 — Metabolic Abnormalities in Septic Shock

System	Abnormality
Glucose metabolism	Hyperglycemia, insulin resistance
Hormonal drivers	TNF, IL-1, cortisol, glucagon, GH, catecholamines
Immune effect	↓ Neutrophil function
Endocrine	Relative adrenal insufficiency
Special syndrome	Waterhouse-Friderichsen (adrenal necrosis)
Cellular respiration	↓ Oxidative phosphorylation
Acid–base	Lactic acidosis

🟥 MASTER TABLE 16 — Stages of Shock (High-Yield Comparison)

Stage	Key Features	Reversibility
Nonprogressive	Neurohumoral compensation, tachycardia, vasoconstriction, cool skin (warm early sepsis)	Reversible
Progressive	Anaerobic glycolysis, lactic acidosis, vasodilation, DIC risk, organ dysfunction	Partially reversible
Irreversible	Lysosomal rupture, myocardial depression (↑ NO), ischemic gut, renal failure	Fatal

🟥 MASTER TABLE 21 — Superantigens & Toxic Shock

Feature	Detail
Organisms	S. aureus, S. pyogenes
Mechanism	Polyclonal T-cell activation
Result	Massive cytokine release
Clinical	Rash, hypotension, shock, death

Stage	Serum Lactate (mmol/L)	Pathophysiology	Clinical Meaning	Exam-Critical Notes
Normal	< 2	Adequate oxygen delivery; aerobic metabolism	Normal perfusion	Rules out tissue hypoxia
Early Sepsis / Compensated Shock	2 – 4	Early tissue hypoperfusion; ↑ anaerobic glycolysis	Occult shock possible; BP may be normal	Lactate ≥2 = red flag
Established Septic Shock	≥ 4	Severe hypoperfusion; microcirculatory failure; mitochondrial dysfunction	Defines septic shock; high mortality	Key diagnostic cutoff
Refractory / Late Septic Shock	Persistently ≥ 4–5	Ongoing cellular hypoxia despite resuscitation	Multiorgan failure	Very poor prognosis
Improving Shock (Lactate Clearance)	↓ ≥10–20% in 6 h	Restored perfusion & metabolism	Good response to treatment	Strong survival predictor

Summary of Shock

🟥 MASTER TABLE 1 — Core Definition & Big Picture of Shock

🟥 MASTER TABLE 2 — Clinical Contexts Where Shock Occurs

🟥 MASTER TABLE 3 — Major Categories of Shock (Core Types)

🟥 MASTER TABLE 4 — Cardiogenic Shock (Expanded)

🟥 MASTER TABLE 5 — Hypovolemic Shock (Expanded)

🟥 MASTER TABLE 6 — Other Important Types of Shock

🟥 MASTER TABLE 7 — Septic Shock: Epidemiology

🟥 MASTER TABLE 8 — Septic Shock: Microbial Triggers

🟥 MASTER TABLE 9 — Innate Immune Activation in Sepsis

🟥 MASTER TABLE 10 — Septic Shock: Hyperinflammatory Response

🟥 MASTER TABLE 11 — Compensatory Immunosuppression in Sepsis

🟥 MASTER TABLE 12 — Endothelial Injury & Vascular Collapse

🟥 MASTER TABLE 13 — Coagulation Abnormalities (DIC in Sepsis)

🟥 MASTER TABLE 14 — Metabolic Abnormalities in Septic Shock

🟥 MASTER TABLE 15 — Organ Dysfunction in Septic Shock

🟥 MASTER TABLE 16 — Stages of Shock (High-Yield Comparison)

🟥 MASTER TABLE 17 — Morphology of Shock

🟥 MASTER TABLE 18 — Clinical Features by Shock Type

🟥 MASTER TABLE 19 — Prognosis

🟥 MASTER TABLE 20 — Treatment Principles

🟥 MASTER TABLE 21 — Superantigens & Toxic Shock

Summary of Shock

🟥 MASTER TABLE 1 — Core Definition & Big Picture of Shock

🟥 MASTER TABLE 2 — Clinical Contexts Where Shock Occurs

🟥 MASTER TABLE 3 — Major Categories of Shock (Core Types)

🟥 MASTER TABLE 4 — Cardiogenic Shock (Expanded)

🟥 MASTER TABLE 5 — Hypovolemic Shock (Expanded)

🟥 MASTER TABLE 6 — Other Important Types of Shock

🟥 MASTER TABLE 7 — Septic Shock: Epidemiology

🟥 MASTER TABLE 8 — Septic Shock: Microbial Triggers

🟥 MASTER TABLE 9 — Innate Immune Activation in Sepsis

🟥 MASTER TABLE 10 — Septic Shock: Hyperinflammatory Response

🟥 MASTER TABLE 11 — Compensatory Immunosuppression in Sepsis

🟥 MASTER TABLE 12 — Endothelial Injury & Vascular Collapse

🟥 MASTER TABLE 13 — Coagulation Abnormalities (DIC in Sepsis)

🟥 MASTER TABLE 14 — Metabolic Abnormalities in Septic Shock

🟥 MASTER TABLE 15 — Organ Dysfunction in Septic Shock

🟥 MASTER TABLE 16 — Stages of Shock (High-Yield Comparison)

🟥 MASTER TABLE 17 — Morphology of Shock

🟥 MASTER TABLE 18 — Clinical Features by Shock Type

🟥 MASTER TABLE 19 — Prognosis

🟥 MASTER TABLE 20 — Treatment Principles

🟥 MASTER TABLE 21 — Superantigens & Toxic Shock